Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Depression 1

Interventions

Oxygen 2 Melatonin 2 Ketamine 2 Ultraviolet Therapy 1 Surveys and Questionnaires 1 Saline Solution 1 Referral and Consultation 1 Psychotherapy, Group 1 Mindfulness-Based Stress Reduction 1 Milnacipran 1 Methylphenidate 1 Fatty Acids, Omega-3 1 Desvenlafaxine Succinate 1 Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Depression × Milnacipran × Clear all

NCT02783430 2025-12-16

KETAPAL

University Hospital, Lille

Phase 2/3 Completed

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡